Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The P2X7 inhibitor, brilliant blue G (BBG), has been reported as a neuroprotective drug against a variety of disorders, including neuropathic pain and brain ischemia. Currently, no studies have examined the potential for BBG to provide neuroprotection in animal models of TBI. The aim of the present study was to investigate the neuroprotective effect of BBG on TBI and to determine the underlying mechanisms. The rats were subjected to a diffuse cortical impact injury caused by a modified weight-drop device, and then divided randomly into three groups: the sham-operated, BBG treatment and vehicle groups. In the BBG treatment group, 50 mg/kg brilliant blue G (BBG; 100% pure), a highly specific and clinically useful P2X7 antagonist, was administered via the tail vein 15 min prior to or up to 8 h following TBI. The co-localization of NeuN and protein kinase Cγ (PKCγ) was followed with immunofluorescent staining. The expression of P2X7, PKCγ and inflammatory cytokines was identified by western blot analysis. Wet-dry weight method was used to evaluate brain edema, and motor function outcome was examined using the neurological severity score. The present study demonstrated that the administration of BBG attenuated TBI-induced cerebral edema and the associated motor deficits. Following trauma, BBG treatment significantly reduced the levels of PKCγ and interleukin-1β in the cortex. The results provide in vivo evidence that BBG exerted neuroprotective effects by attenuating brain edema and improving neurological functions via reducing PKCγ and interleukin-1β levels following TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739 · cited 8×
“Accumulative evidence demonstrates the presence of P2X7 receptors on microglia and the activation of these receptors by ATP triggers microglia release of IL-1 β (43).”
InfluentialParvathenani, L. K., Tertyshnikova, S., Greco, C. R., Roberts, S. B., Robertson, B., & Posmantur, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209478200 · Cited by 488 · cited 1×
“Microglia activation is associated with a number of CNS diseases, including Alzheimer's, Parkinson's disease, amyotrophic lateral sclerosis and multiple sclerosis (7-11).”
Psychiatric Disorders Following Traumatic Brain Injury: Their Nature and Frequency
Whelan-Goodinson, R., Ponsford, J., Johnston, L., & Grant, F. (2009) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0b013e3181a712aa · Cited by 310
Traumatic brain injury: physiology, mechanisms, and outcome
Nortje, J., & Menon, D. K. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200412000-00011 · Cited by 219 · cited 1×
“Traumatic brain injury (TBI) is a complex and devastating clinical condition mediated at least in part by pro‑inflammatory cytokines that produce neuronal loss, axonal destruction and demyelination during the secondary injury cascade (1).”
Herx, L. M., Rivest, S., & Yong, V. W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2232 · Cited by 190 · cited 1×
“Notably, IL-1β exhibited a prolonged induction in multiple pre-clinical models of TBI (16-21), and increased IL-1β levels in the CSF and brain was positively correlated with elevated intracranial pressure (ICP) and unfavorable outcomes in TBI patients (22-24).”
Cited by
Yue, N., Huang, H., Zhu, X., Han, Q., Wang, Y., Li, B., Liu, Q., Wu, G., Zhang, Y., & Yu, J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0865-y · Cited by 334
Self-citationTraumatic Axonal Injury: Mechanisms and Translational Opportunities
Hill, C. S., Coleman, M. P., & Menon, D. K. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.03.002 · Cited by 306
Cheung, W. Y., Fritton, J. C., Morgan, S. A., Seref-Ferlengez, Z., Basta-Pljakic, J., Thi, M. M., Suadicani, S. O., Spray, D. C., Majeska, R. J., & Schaffler, M. B. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2740 · Cited by 89
D’Amico, R., Fusco, R., Siracusa, R., Impellizzeri, D., Peritore, A. F., Gugliandolo, E., Interdonato, L., Sforza, A. M., Crupi, R., Cuzzocrea, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126471 · Cited by 51
“P2X7R is overactivated due to ATP release, resulting in anion imbalance and triggering of microglia, that additionally exacerbate cell damage [14,15].”
Background
Metadata
- Authors
- WANG, Y.-C., CUI, Y., CUI, J.-Z., SUN, L.-Q., CUI, C.-M., ZHANG, H.-A., ZHU, H.-X., LI, R., TIAN, Y.-X., & GAO, J.-L.
- Venue
- Molecular Medicine Reports
- Publisher
- Spandidos Publications
- Published
- 2015-04-14
- Volume
- 12
- Issue
- 2
- Pages
- 2149-2154
- ISSN
- 1791-2997 (ISSN-L)
- 1791-3004
- OpenAlex
- W1981709409
- Cited by
- 34
- References
- 5
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats. https://app.cochat.ai/papers/10.3892/mmr.2015.3607
- The paper
- WANG, Y.-C., CUI, Y., CUI, J.-Z., SUN, L.-Q., CUI, C.-M., ZHANG, H.-A., ZHU, H.-X., LI, R., TIAN, Y.-X., & GAO, J.-L. (2015). Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2015.3607
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.